@tempriantherapeutics.com
Temprian Therapeutics is an early-stage biotechnology company treating vitiligo through a novel treatment that blocks the autoimmune response to melanocytes.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
PNG
About
Description
Temprian Therapeutics is an early-stage biotechnology company that is revolutionizing the treatment of vitiligo, a chronic autoimmune disease that causes patches of skin to lose pigmentation. With over 25 years of research in gene therapies, autoimmune diseases, and dermatology, Temprian Therapeutics is developing a novel and safe treatment to address this condition. The company's lead program is a platform technology that targets autoimmune diseases such as vitiligo by injecting a genetically modified DNA plasmid to reverse the debilitating immune response.
Unlike traditional treatments, Temprian Therapeutics' systemic approach impacts lesions across the body, offering hope to the estimated 35 to 70 million people worldwide who suffer from vitiligo. With a team of dedicated doctors and business leaders, Temprian Therapeutics is committed to advancing the field of vitiligo and creating a safe and effective treatment for all. Contact them today to learn more about their groundbreaking work
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories